Newsfiscal.ai
TD Cowen Adjusts Price Target for LENZ Therapeutics
· Published
Article summary
TD Cowen has lowered its price target for LENZ Therapeutics, Inc. from $60 to $50.
An excerpt from the original article.TD Cowen has lowered its price target for LENZ Therapeutics, Inc. from $60 to $50.
An excerpt from the original article.
Comments —
Loading comments…